Pharmacogenomics : social, ethical, and clinical dimensions /
Saved in:
| Imprint: | Hoboken, N.J. : Wiley-Liss, c2003. |
|---|---|
| Description: | xii, 368 p. : ill. ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4872832 |
Table of Contents:
- Foreword
- Preface
- Part I. Introduction: Science and Society
- 1. Public Attitudes About Pharmacogenomics
- 2. Pharmacogenomics: Pharmacology and Toxicology in the Genomics Era
- 3. The Implications of Population Genetics for Pharmacogenomics
- Part II. Research and Development Challenges and Considerations
- 4. Genome Research and Minorities
- 5. Drug Development Strategies
- 6. Drug Development, Regulation, and Genetically Guided Therapy
- 7. Intellectual Property and Commercial Aspects of Pharmacogenomics
- Part III. Clinical Applications
- 8. Integration of Pharmacogenomics into Medical Practice
- 9. Clinical Utility of Pharmacogenetics and Pharmacogenomics
- 10. Medical Liability for Pharmacogenomics
- 11. The Challenges of Pharmacogenomics for Pharmacy Education, Practice, and Regulation
- Part IV. The Social Dimension
- 12. Economic Implications of Pharmacogenomics
- 13. Pharmacogenomics and the Social Construction of Identity
- 14. Pharmacogenomics: Considerations for Communities of Color
- 15. Constitutional Issues in the Use of Pharmacogenomic Variations Associated With Race
- Part V.
- Epilogue: Policy Prescriptions
- Pharmacogenomics and Minority Populations: General Population Survey Questionnaire
- Index
